These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30616967)

  • 21. Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.
    Idelevich EA; Groß U; Becker K; Bader O
    Diagn Microbiol Infect Dis; 2018 May; 91(1):52-54. PubMed ID: 29422272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azole resistance in canine and feline isolates of Aspergillus fumigatus.
    Talbot JJ; Kidd SE; Martin P; Beatty JA; Barrs VR
    Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():37-41. PubMed ID: 26387063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
    Beernaert LA; Pasmans F; Van Waeyenberghe L; Dorrestein GM; Verstappen F; Vercammen F; Haesebrouck F; Martel A
    Antimicrob Agents Chemother; 2009 May; 53(5):2199-201. PubMed ID: 19258265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
    Bueid A; Howard SJ; Moore CB; Richardson MD; Harrison E; Bowyer P; Denning DW
    J Antimicrob Chemother; 2010 Oct; 65(10):2116-8. PubMed ID: 20729241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.
    Verweij PE; Te Dorsthorst DT; Rijs AJ; De Vries-Hospers HG; Meis JF
    J Clin Microbiol; 2002 Jul; 40(7):2648-50. PubMed ID: 12089298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.
    Fraczek MG; Bromley M; Buied A; Moore CB; Rajendran R; Rautemaa R; Ramage G; Denning DW; Bowyer P
    J Antimicrob Chemother; 2013 Jul; 68(7):1486-96. PubMed ID: 23580559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
    Chen J; Li H; Li R; Bu D; Wan Z
    J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China.
    Deng S; Zhang L; Ji Y; Verweij PE; Tsui KM; Hagen F; Houbraken J; Meis JF; Abliz P; Wang X; Zhao J; Liao W
    Emerg Microbes Infect; 2017 Dec; 6(12):e109. PubMed ID: 29209054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
    Verweij PE; Mensink M; Rijs AJ; Donnelly JP; Meis JF; Denning DW
    J Antimicrob Chemother; 1998 Sep; 42(3):389-92. PubMed ID: 9786480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
    Manavathu EK; Cutright JL; Loebenberg D; Chandrasekar PH
    J Antimicrob Chemother; 2000 Aug; 46(2):229-34. PubMed ID: 10933645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France.
    Choukri F; Botterel F; Sitterlé E; Bassinet L; Foulet F; Guillot J; Costa JM; Fauchet N; Dannaoui E
    Med Mycol; 2015 Aug; 53(6):593-6. PubMed ID: 26026171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
    Alanio A; Sitterlé E; Liance M; Farrugia C; Foulet F; Botterel F; Hicheri Y; Cordonnier C; Costa JM; Bretagne S
    J Antimicrob Chemother; 2011 Feb; 66(2):371-4. PubMed ID: 21131690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
    Cuenca-Estrella M; Rodríguez-Tudela JL; Mellado E; Martínez-Suárez JV; Monzón A
    J Antimicrob Chemother; 1998 Oct; 42(4):531-3. PubMed ID: 9818755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
    Lescar J; Meyer I; Akshita K; Srinivasaraghavan K; Verma C; Palous M; Mazier D; Datry A; Fekkar A
    J Antimicrob Chemother; 2014 Dec; 69(12):3244-7. PubMed ID: 25125676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, mechanisms and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan.
    Wang HC; Huang JC; Lin YH; Chen YH; Hsieh MI; Choi PC; Lo HJ; Liu WL; Hsu CS; Shih HI; Wu CJ; Chen YC
    Environ Microbiol; 2018 Jan; 20(1):270-280. PubMed ID: 29124846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus: Should we be concerned?
    Vaezi A; Fakhim H; Javidnia J; Khodavaisy S; Abtahian Z; Vojoodi M; Nourbakhsh F; Badali H
    J Mycol Med; 2018 Mar; 28(1):59-64. PubMed ID: 29496370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azole cross-resistance in Aspergillus fumigatus.
    Mosquera J; Denning DW
    Antimicrob Agents Chemother; 2002 Feb; 46(2):556-7. PubMed ID: 11796377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
    J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
    Snelders E; van der Lee HA; Kuijpers J; Rijs AJ; Varga J; Samson RA; Mellado E; Donders AR; Melchers WJ; Verweij PE
    PLoS Med; 2008 Nov; 5(11):e219. PubMed ID: 18998768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stable prevalence of triazole-resistance in Aspergillus fumigatus complex clinical isolates in a Belgian tertiary care center from 2016 to 2020.
    Resendiz-Sharpe A; Merckx R; Verweij PE; Maertens J; Lagrou K
    J Infect Chemother; 2021 Dec; 27(12):1774-1778. PubMed ID: 34518094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.